Jason Lok
Pain Medicine · Auburn, NYNPI 1700857299
Payments from drug & device makers
Across 109 payments — averaging $53.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$680
- Si-bone, Inc.$177
- Abbott$163
- Scilex Pharmaceuticals Inc.$121
- SPR Therapeutics, Inc$96
- plus $526 from 17 others
What the payments were for
- Travel & lodging$2,91450%
- Food & beverage$2,90550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 39 | $4,054 |
| Boston Scientific | 18 | $680 |
| Si-bone, Inc. | 3 | $177 |
| Abbott | 6 | $163 |
| Scilex Pharmaceuticals Inc. | 9 | $121 |
| SPR Therapeutics, Inc | 7 | $96 |
| Foundation Fusion Solutions, LLC | 1 | $78 |
| Averitas Pharma Inc. | 2 | $59 |
| Avanos Medical | 2 | $45 |
| Vertiflex, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 3 | $40 |
| Nevro Corp. | 2 | $38 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Vertos Medical, Inc. | 2 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Tersera Therapeutics LLC | 2 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| IBSA Pharma Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| Fidia Pharma USA Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$1,444
- INTELLIS ADAPTIVESTIM$1,369
- WaveWriter Alpha Prime 16$114
- GENERAL PAIN MANAGEMENT$102
How this compares
$5,819 in reported general payments places this provider in the 75th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 90 | $1,850 |
| Gabapentin | 107 | $1,517 |
| Meloxicam | 527 | $912 |
| Topiramate | 19 | $308 |
| Amitriptyline Hcl | 18 | $106 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Auburn
- Gary SchwartzBrooklyn$756K
- Amitabh GulatiNew York$627K
- William CaldwellStony Brook$550K
- Brian DurkinPort Jefferson$459K
- Grace FordeNew Hyde Park$398K
- David SpinnerNew York$391K
- John MarkmanRochester$300K
- Naum ShaparinBronx$178K
- Ashraf HenryAmherst$168K
- Kenneth ChapmanStaten Island$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.